bmi to qualify for glp 1 A Balancing Act: GLP-1 Receptor Agonists Non-Diabetic Obesity – Clinical Correlations What BMI Qualifies for GLP-1

Los mdicos de los Hospitales Continental estn capacitados en el manejo de la terapia con medicamentos GLP-1 y ofrecen apoyo completo desde el diagnstico hasta la atencin de seguimiento

Conclusion Our study suggests that among older adults with type 2 diabetes treated with levothyroxine, initiation and continued use of GLP-1RA was associated with an increased risk of atrial fibrillation or flutter compared to SGLT2 inhibitors, without an elevation on stroke risk

But GLP-1 medications also appear to have anti-inflammatory, vascular, and possibly antithrombotic [blood clot-reducing] effects

Consider restarting medication There is no shame in restarting

Also note that abruptly stopping GLP-1 medication is not recommended

The agency began its review in mid-2023 following reports of suicidal thoughts among some patients taking GLP-1 drugs for weight loss